Scienmag

FEBRUARY 11, 2021

A new largescale genetic analysis has found biological mechanisms that contribute to making people more susceptible to muscle weakness in later life, finding that diseases such as osteoarthritis and diabetes may play a large role in susceptibility.

Genetic Analysis 40

Genetic Analysis Genetics Research Gene 40

XTalks

DECEMBER 1, 2020

Over the past several years, personalized medicine has led the charge in medical innovation, leading drug development efforts as well as furthering the research community’s understanding of human disease states.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

XTalks

JULY 29, 2024

Understanding Late-Onset Pompe Disease Pompe disease, also known as glycogen storage disease type II (GSD2) or acid maltase deficiency, is a rare genetic disorder with an approximate incidence of one in 40,000 births characterized by the deficiency of the enzyme acid alpha-glucosidase (GAA).

Clinical Trials 105

Clinical Trials Clinical Trials Trials Research 105

pharmaphorum

APRIL 5, 2022

Genetic analysis of tumours can reveal mutations that are fuelling cancers growth, some of which can be targeted with treatment, they note. However, genomics alone is not able to reliably select drug combinations, and layering in their proteomics approach can improve the predictive power of this approach.

Protein 67

Protein Genome Genomics Genetic Analysis 67

The Pharma Data

JANUARY 7, 2021

Now, research is helping to bring genetic risks for people of various racial and ethnic groups into focus. Researchers from the USC Center for Genetic Epidemiology in Los Angeles and the Institute of Cancer Research in London led the study. THURSDAY, Jan. Men of Asian ancestry inherit about three-quarters the risk of white men.

Gene 52

Gene Genetics Genome Genomics 52

Delveinsight

FEBRUARY 25, 2021

Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing.

DNA 52

DNA In-Vivo Genetics Medicine 52

pharmaphorum

NOVEMBER 16, 2022

The risk profile of developing AMD has been studied for years,” he said, “and more than 50% of a given individual’s risk profile is dependent on their genetics. So, pegcetacoplan blocks an inflammatory pathway that appears to be central for geopathic genesis based on extensive genetic analysis,” Dr Wykoff concluded.

Genetics 105

Genetics Trials Clinical Trials Clinical Trials 105

The Pharma Data

DECEMBER 11, 2020

And even when Black people with AML have the same access to treatment as white patients, their survival is shorter — something genetic differences might explain. Chancellor Donald, assistant professor of medicine, hematology and medical oncology at Tulane University School of Medicine in New Orleans, who led the briefing.

Genetics 52

Genetics Clinical Trials Clinical Trials Genetic Analysis 52

The Pharma Data

SEPTEMBER 3, 2020

Our new study offers an important basis from which to start developing new treatment strategies for a rare form of cancer, which starts in the hormone-producing cells of the pancreas,” noted Dr Anguraj Sadanandam, team leader in Systems and Precision Cancer Medicine at The ICR, London. “We

Research 52

Research Genetic Analysis Gene Scientist 52

XTalks

JANUARY 6, 2025

Whether its the integration of nanotechnology in medicine, the evolution of point-of-care (POC) diagnostics or the transformative impact of CRISPR and regenerative medicine, these biotech trends are pushing scientific boundaries and creating new opportunities for businesses and researchers alike. percent from 2022 to 2030.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111